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Abstract
Background: Lymphatic filariasis (LF) is a mosquito-borne filarial disease targeted for elimination by the year 2020.
The Republic of Togo undertook mass treatment of entire endemic communities from 2000 to 2009 to eliminate
the transmission of the disease and is currently the first sub-Saharan African country to be validated by WHO for
the elimination of LF as a public health problem. However, post-validation surveillance activities are required to ensure
the gains achieved are sustained. This survey assessed the mosquito vectors of the disease and determined the presence
of infection in these vectors, testing the hypothesis that transmission has already been interrupted in Togo.
Method: Mosquitoes were collected from 37 villages located in three districts in one of four evaluation units in the
country. In each district, 30 villages were selected based on probability proportionate to size; eight villages (including
one of the 30 villages already selected) where microfilaremia-positive cases had been identified during post-treatment
surveillance activities were intentionally sampled. Mosquitoes were collected using pyrethrum spray collections (PSC) in
households randomly selected in all villages for five months. In the purposefully selected communities, mosquitoes
were also collected using human landing collections (HLC) and exit traps (ET). Collected mosquitoes were identified
morphologically, and the identification of Wuchereria bancrofti DNA in the mosquitoes was based on the
pool screening method, using the LAMP assay.
Results: A total of 15,539 mosquitoes were collected during the study. Anopheles gambiae (72.6%) was the
predominant LF vector collected using PSC. Pool screen analysis of 9191 An. gambiae in 629 pools revealed
no mosquitoes infected with W. bancrofti (0%; CI: 0–0.021).
Conclusions: These results confirm the findings of epidemiological transmission assessment surveys conducted
in 2012 and 2015, which demonstrated the absence of LF transmission in Togo. The challenges of implementing
molecular xenomonitoring are further discussed.
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Background
Lymphatic filariasis (LF), the second leading infectious
cause of disability worldwide, is endemic in 73 countries,
an estimated 120 million people are infected with the
parasites, and 40 million people suffer from complications.
The World Health Organization (WHO) outlines specific
steps for endemic countries to achieve and document
interruption of transmission of LF [1]. Baseline mapping is
conducted to identify LF-endemic areas of the country,
followed by at least five rounds of annual mass drug ad-
ministration (MDA) in endemic areas. Concurrent moni-
toring and evaluation (M&E) are conducted in these areas
under MDA to ensure that targets are met and determine
when MDA can be stopped. Transmission assessment sur-
veys (TAS) are undertaken after MDA has been stopped,
followed by a five-year post-validation period to verify the
absence of resurgence.
Togo is a West African country with a population of
6.7 million, with 32% of the population living below the
poverty line [2]. The country is divided into six regions
and 40 health districts. District medical teams support
more than 650 rural health centres nationwide. Eight of
the 40 districts were endemic to LF. Those districts belong
to three distinct endemic foci and were co-endemic for LF
and onchocerciasis.
Togo was one of the first African countries to implement
a national LF elimination programme [3]. The national LF
programme started in 2000 with baseline mapping followed
by mass drug administration in the LF endemic districts.
The last MDA in Togo was conducted in 2009. LF surveil-
lance in Togo has consisted of:
 a nationwide passive surveillance system,
implemented from 2006 through 2015. The
surveillance consisting of two components: (i) a
network of 47 laboratories, in which laboratory
technicians routinely search for Wuchereria
bancrofti microfilaria on nocturnal blood smears
collected for malaria diagnosis, and (ii) a network of
20 healthcare facilities not covered by the laboratory
network, in which nurses regularly collect dried
blood that is tested for Og4C3 antigen [4].
 a successful implementation of two post-MDA
transmission assessment surveys (TAS) using the
WHO’s guidelines in the eight endemic districts in
2012 and 2015, three and five years after stopping
MDA, respectively, have been carried out.
The results of these surveillance activities demon-
strated that there was no ongoing LF transmission in the
country [3, 5].
Togo also conducted a national campaign to distribute
insecticide-treated bed nets (ITNs) in 2004 followed by
subsequent distribution of long-lasting insecticide-treated
nets (LLINs) to achieve universal coverage [6–8]. These
campaigns likely significantly changed the profile of the
LF vector population in Togo, although entomologic stud-
ies are lacking.
Recently, Togo became the first country in sub-Saharan
Africa to receive WHO validation of the elimination of LF
as a public health problem [1, 9, 10]. Before this announce-
ment, the country began molecular xenomonitoring (MX)
for LF [11], to collect more evidence demonstrating the
absence of LF transmission. This work, presented here,
investigated the absence of LF transmission in mosquito
populations as recommended by the WHO, with the
hypothesis that transmission has already been inter-
rupted in Togo [12].
Methods
Study design
The study had limited funding, and as such, it was im-
portant to consider various factors in developing the
sampling. The development of the sampling strategy
took place during a two-day meeting with the LF
Programme officers and entomologists. Following exten-
sive discussions, the least expensive option of using
community volunteers as against trained entomologists
was adopted for the study.
Factors considered in designing the sampling strategy
The factors we considered in designing the sampling
strategy include financial and human resources, work-
load and the local epidemiological context.
Financial resource factors affecting the sampling strategy
are: (i) available budget; (ii) distances to be covered and as-
sociated transportation costs; (iii) daily allowances for ento-
mologists, community volunteers and supervisors; and (iv)
sourcing and purchasing of consumables and supplies.
Human resource factors considered are: (i) availability
and skills of experienced entomologists versus community
volunteers; (ii) need for supervision of volunteers during
collections; (iii) training requirements (best practices for
mosquito collection and storage) and logistics (training
venues, meals and transportation allowances); (iv) need to
develop human capacity for future public health needs;
and (v) security and safety of trained entomologists.
Sampling decisions were also based on workload: (i)
one-time versus repeated mosquito collections (i.e. prob-
ability of catching an infected mosquito in a one-time col-
lection as compared to repeated collections); (ii) number
of households that can be sampled per day; and (iii) total
number of mosquitoes required.
Finally, the regional, national, and local epidemiological
context affecting sampling are related to: (i) vector trans-
mission dynamics (impact of seasonality on mosquito
species and LF transmission); (ii) number of transmis-
sion assessment survey (TAS) evaluation units (EU) to
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investigate (weighing relative benefits of sparse cover-
age of all EUs against comprehensive coverage of one
EU); and (iii) relative emphasis on high-risk versus low-
risk areas in the sample.
Study area
The study was conducted in the Savanes Region in the
northern part of Togo (Fig. 1). Three of the five districts
in the region, Kpendjal, Cinkassé and Tone, were previ-
ously endemic for LF. The survey was conducted in the
three districts grouped into one evaluation unit (EU) be-
cause of their proximity to Ghana in the West, Burkina
Faso to the North and Benin to the East, where trans-
mission of LF is reported to be ongoing.
Selection of sampling sites
A two-stage sampling method was used to select the
sampling sites. In the first stage, villages were chosen,
and in the second, households (HHs) were selected
within each village. [13]. All communities with popula-
tion greater than 5000 were excluded from the sampling
because the potential for transmission in urban areas is
low [14, 15]. Thirty villages were selected in the EU with
probability proportional to size.
In addition, eight additional villages previously known
to have reported a microfilaremia positive case, either
through monitoring and evaluation, TAS or passive sur-
veillance, were also assessed. The last microfilaremia
positive case was identified in 2015. One of the villages
purposefully selected was also selected by probability
proportionate to size; therefore, 37 villages were sur-
veyed in total. The geolocation of each surveyed village
was recorded.
Households were sampled to cover the entire village as
much as possible, by the end of the sampling period.
Each village was divided into four approximately equal
sections. Households in each section were numbered
consecutively and selected randomly (using a dice). The
household head was approached, and consent sought. If
a household refused to participate, a different household
was selected. New households were selected for each
sampling day, and households from which mosquitoes
Fig. 1 Study region and communities. Base map source: Institut national de la Statistique, des études économiques et démographiques, Togo
(INSEED). Software: QGIS 2.18.14 (Las Palmas) (Quantum GIS Geographic Information System, Quantum GIS Development Team, Open Source
Geospatial Foundation Project)
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were previously collected were excluded from the selec-
tion unless the number of households in the section was
exhausted.
Mosquito collection
This entomological study was undertaken over five months
during the peak dry season (October 2016–February 2017),
with the aim of collecting as many mosquitoes as possible.
In each study community, mosquito collection was done
twice every month. The estimated sample size was 2000
vector mosquitoes per IU, required to estimate an infection
rate of 1% with a power of 0.80 [16].
In each village, community volunteers were identified
and trained for mosquito collection and storage. Mosquito
collections were primarily done using the pyrethrum spray
catch (PSC) method. On each mosquito collection day,
households were randomly selected from each section and
mosquitoes collected, using the PSC method. The day
before the collection, consent was obtained from occu-
pants of the households, they were asked to keep bed-
room doors and windows closed the following morning.
Mosquitoes were collected early in the morning between
05:00 h and 08:00 h by two trained collectors. The occu-
pants were asked to remove or cover all food items in the
room. Potential mosquito hiding places (under the bed,
tables) were searched and disturbed to displace any resting
mosquito White sheets were laid on the floor and other
surfaces in the rooms. The room was then sprayed with
pyrethrum insecticide and left for about 15 min, after
which the white sheets were inspected for any dead or
knocked down mosquitoes.
In the eight purposefully selected communities, mosquito
collection was also done using human landing collection
(HLC) method and exit trap collection (ETC). Both HLC
and ETC were undertaken in randomly selected house-
holds, different from the households where PSC was
undertaken.
All collected mosquitoes were placed in a Petri dish
labelled with the village code. Each Petri dish contained
silica gel in a ball of cotton wool, to keep the mosquitoes
dry. The Petri dishes from all villages were sent to the
district on a specified date. Once a month, a central
team visited all districts to collect the mosquitoes and
deliver them to the entomology laboratory of the depart-
ment of “Unité de Recherche en Ecotoxicologie (URET)”
of Sciences faculty of the University of Lomé (Togo).
Sample processing
Mosquito genera and species identification were conducted
at the entomology laboratory of the University of Lomé
using morphological identification keys [17, 18]. All
mosquitoes collected by the PSC and ETC were grouped
in pools of 25 or less, according to the village and method
of collection. The pooled mosquitoes were then sent to
the NTD reference laboratory of the Parasitology Depart-
ment, Noguchi Memorial Institute for Medical Research
(University of Ghana) for molecular identification of W.
bancrofti infection in the vector species. DNA was ex-
tracted from the mosquito pools using the DNeasy Tissue
Kit (Qiagen, Valencia, California, USA), and molecular
identification of W. bancrofti was done using the LAMP
method [19–21]. All reactions included a positive (W.
bancrofti DNA) and negative (water) control (Fig. 2) The
positive control is W. bancrofti DNA extracted from
microfilariae positive mosquitoes, in previous studies from
Sierra Leone [20]. All positives were confirmed using the
conventional PCR method for the determination of W.
bancrofti infection [22].
Data analysis
The number of mosquitoes collected in each month was
evaluated regarding the rainfall data for each collection
month. The Poolscreen 2.0 software was used to analyse
the pool screening results [23]. The survey costs were
grouped into categories and presented in a table. Survey
costs were divided into the following categories: personal
allowance (research team and vector collectors), sup-
plies, transportation, communication, and others. The
unit cost per sample was estimated as the sum of the
unit cost for collecting each sample and the unit cost for
laboratory analysis.
All levels of statistical significance were determined at the
95% confidence limit. Graphs were drawn using GraphPad
Prism 7 (GraphPad Software, Inc., La Jolla, California, USA)
and Microsoft Excel (Microsoft Corporation, Redmond,
Washington, USA). The geolocation data were imported
into QGIS 2.18 (QGIS Geographic Information System,
QGIS Development Team, Open Source Geospatial
Foundation Project) for mapping.
Results
A total of 15,568 mosquitoes were collected over the en-
tire 5-month period: 10,859 by PSC, 3798 by ETC and
Fig. 2 The reaction tubes after LAMP reaction. The positive control
(Tube 7) turned white when visualized under a UV source. The
negative samples (tubes 1–6) and negative control (tube 8) are clear
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911 by HLC. Table 1 presents the number of mosquitoes
per collection method and IU. More mosquitoes were
collected using the PSC.
Anopheles gambiae (s.l.) (n = 7893), the main vectors
of LF in West Africa, was the dominant mosquito spe-
cies (72.6%) collected using the PSC, followed by Culex
quinquefasciatus (n = 2942), Aedes (n = 15), Mansonia
(n = 3) and six other mosquito species. The mean number
of An. gambiae collected per village using the PSC was
213. For the ETC, 2333 An. gambiae, 1374 C. quinquefas-
ciatus, 47 Aedes and 44 Mansonia were collected. The
mean number of An. gambiae collected per village using
ETC was 63. For HLC, a total of 656, 233, 12 and 10 mos-
quitoes were reported for the An. gambiae, C. quinquefas-
ciatus, Aedes, and Mansonia species, respectively. The
mean number of An. gambiae collected per village using
HLC was 82. Based on HLC, the overall biting rate was at
the highest in October 2016, with 23 bites/person/night
(bpn) for indoor and 22 bpn for outdoor collections, and
lowest in February 2017 with 1 bpn for both indoor and
outdoor collections.
Anopheles spp. were processed for W. bancrofti infec-
tion. Out of 9191 samples processed in 629 pools, none
(0%) were found positive (95% CI: 0–0.021). Table 2 pre-
sents the information on the number of pools analysed
per IU. Of the mosquitoes analysed, 7623 were either
fed or gravid, and 1568 were unfed. Of the An. gambiae
collected, 6992 were analysed using PSC, and the re-
mainder using ETC.
The costs of this survey are summarized in Table 3,
with the aim of guiding other control programmes plan-
ning to undertake wide-scale entomological evaluations
for LF elimination. An estimated $35,910.40 was spent
on this survey. The main costs incurred include the
training of the community mosquito collectors and
supervisors, field mosquito collection (person-time), and
sample processing charges. Other costs included ethical
application fees, photocopies and vehicle maintenance
charges. Based on the cost estimates for the study, the
approximate costs for sample collection per IU, cost for
sample collection per week, cost per pool collected and
processed and cost per mosquito collected and proc-
essed were estimated. The cost per mosquito collected
and processed was estimated at 3.1 US$.
Discussion
In Togo, MDA conducted during the past ten years has
dramatically reduced lymphatic filariasis (LF) incidence
in all implementation units (IU) as demonstrated by the
low prevalence of circulating filariasis antigenemia ob-
tained during the two TAS conducted during the five
years after MDA was stopped [3]. Despite the very low
infection rate in the human population, and the prior
submission to WHO of a dossier of evidence supporting
the elimination of LF as a public health problem in
Togo, this study of W. bancrofti in the vector was con-
ducted to confirm the results of the epidemiological sur-
veys. As WHO states, the establishment of post-validation
surveillance is important to prevent recrudescence of in-
fection and renewed transmission [9]. Efficient and sensi-
tive methods are needed to detect this recrudescence risk,
and molecular xenomonitoring is gaining recognition as
one of the tools to be employed as a surveillance tool in
the endgame [15, 21, 24–27].
The molecular analysis of the An. gambiae in this
study revealed no infection with W. bancrofti, which is
consistent with the very low antigen prevalence observed
during the TAS conducted from 2010 to 2015 [3, 5, 28].
In this study, culicine mosquitoes were not analysed,
based on the assumption that they are not known vec-
tors of LF in West Africa [29]. In fact, studies conducted
in Togo in the 1960s revealed An. gambiae, An. funestus,
An. pharoensis, Mansonia africana and M. uniformis to
be naturally infected with W. bancrofti. The authors
Table 1 Number and species of mosquitoes by collection method and district
Method District No. of communities An. gambiae Mean An. gambiae Culex spp. Ae. aegypti Mansonia spp. Other species
PSC Tone 21 3956 188 1890 8 1 6
Cinkasse 6 1885 314 620 7 2 0
Kpendjal 10 2052 205 432 0 0 0
Total 37 7893 213 2942 15 3 6
ETC Tone 3 1008 48 970 25 7 0
Cinkasse 3 683 114 36 9 18 0
Kpendjal 2 642 64 368 13 19 0
Total 37 2333 63 1374 47 44 0
HLC Tone 3 329 110 160 6 1 0
Cinkasse 3 214 71 16 7 7 0
Kpendjal 2 113 57 57 1 1 0
Total 8 656 82 233 14 9 0
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suggested that only the first three species seemed to be
vectors, with An. gambiae being a proven local vector of
W. bancrofti in Togo [30]. Nonetheless, more recent
surveys in Kano (Nigeria) revealed L3 W. bancrofti in-
fection in Culex quinquefasciatus, with others also
reporting infection and infectivity rates in Culex mos-
quitoes [29, 31, 32]. As such, in the light of changing
vector abundance and transmission dynamics, future
surveys should also focus on mosquito species previ-
ously considered as non-vectors, since parasite DNA
can be detected in both vector and non-vector mosqui-
toes [21, 33].
WHO recommendations for the use of PCR on pools
of mosquitoes for end-point assessment and post-MDA
surveillance suggest that molecular xenomonitoring and
mosquito sampling assessment should focus on individual
Table 2 Number of mosquitoes and pools processed per district
Implementation unit No. of pools Average
pool size
No. of An.
gambiae processed
No. of An.
gambiae collected
% of An. gambiae
processed
Positive 95% CI
Cinkasse 166 15.9 2646 2782 95.1 0 0–0.073
Kpendjal 172 14.5 2495 2807 88.9 0 0–0.077
Tone 291 13.9 4050 5283 76.7 0 0–0.047
Total 629 14.6 9191 10,872 84.5 0 0–0.021
Abbreviation: CI, confidence interval
Table 3 Cost of survey
Item Cost (CFA Francs) Approximate cost (US$) %
Consultancy Per diem 500,000.0 874.10 2.43
Transport 120,000.0 209.800 0.58
Training Central level per diem 1,127,000.0 1970.3 5.49
Fuel 298,905.0 522.60 1.46
Allowance for supervisors and mosquito collectors 568,000.0 993.00 2.77
Transport for participants 364,000.0 636.40 1.77
Training venues and meals 356,750.0 623.70 1.74
Field collection Central level per diem 1,818,000.0 3178.30 8.85
Allowances for collectors and supervisors 3,465,000.0 6057.70 16.87
Transport for supervisors 376,275.0 657.80 1.83
Field supplies 2,835,443.0 4957.10 13.80
Other consumables 255,500.0 446.70 1.24
Fuel 617,000.0 1078.70 3.00
Others 98,350.0 171.90 0.48
Sample processing Mosquito identification 676,000.0 1181.80 3.29
Shipment of samples 120,000.0 209.80 0.58
Laboratory processing charges 5,968,120.0 10,433.80 29.05
Others expenses Ethics application 200,000.0 349.70 0.97
Vehicle maintenance 300,400.0 525.20 1.46
Data management 200,000.0 349.70 0.97
Communication 214,395.0 374.80 1.04
Photocopies 61,630.0 107.70 0.30
Total 20,540,768.0 35,910.40 100.00
Summary Estimates
~ Sample collection cost per district 8492.20 US$
~ Sample collection cost per week 2547.70 US$
~ Cost per pool collected and processed 45.40 US$
~ Cost per mosquito collected and processed 3.10 US$
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villages (or a cluster of villages when villages are small), ra-
ther than on implementation units [16]. Here, the mosqui-
toes were processed according to the village and IU of the
collection. However, whether processing approximately
200 mosquitoes per village (especially where microfilariae
positive individuals were identified during surveillance) is
enough to identify residual infection remains a matter of
debate. Further statistics and modelling analyses might be
required to resolve this challenge. While the sample sizes
per IU were met, the possibilities of missing communities
with the low residual transmission remain, since not all
villages in the IUs were assessed. Implementing the WHO
recommendation will require (i) more frequent mosquito
collections per month in each community to have a large
enough sample size, and (ii) mosquito collection in many
more villages. These will ultimately increase the cost of
xenomonitoring surveys. Finally, while the mosquitoes
processed by pool screening were not presented according
to catch type and species, due to the absence of infection,
the number of mosquitoes collected per village using PSC
was higher. A recent study showed that collecting mosqui-
toes using PSC may be a better tool for xenomonitoring
compared to ETC [34]. As such further studies may focus
on using PSC alone or other epidemiologically relevant
tools such as gravid traps.
Given the very low parasite detection during TAS, we
wanted to collect and analyse as many mosquitoes as
possible, to enable the detection of very low W. bancrofti
infection in the mosquitoes. While the survey was ini-
tially planned for all four EUs in the country, with a
large number of sites per EU (for good coverage, consid-
ering that this was the first post-validation survey for the
country), we ultimately could not achieve both with the
available budget, so we elected to conduct the survey in
many households but in only the highest risk EU. The
cost for the survey covered by the programme was ap-
proximately 35,910.00 US$. The major cost components
were the personnel (34%), laboratory processing (32.3%),
field supplies (15%) and transportation costs (8.6%). It is,
however, worth mentioning that additional reagents
(~3000.00 US$) were donated, by the Noguchi Centre,
to enable processing of as many samples as possible.
Based on these, the mean approximated cost spent per
village is 1051 US$ (including personnel, and sample
processing costs). In designing the sampling strategy,
various factors and scenarios were considered to arrive
at the most cost-effective design. The preferred sampling
strategy will differ from country to country, and there-
fore so will the cost differ [35].
Conclusions
The post-validation molecular xenomonitoring survey in
Togo has revealed the absence of infection in the An.
gambiae vectors of LF, confirming the results of TAS
and surveillance activities that led to the validation of
elimination of LF as a public health problem in Togo.
The application of molecular xenomonitoring was not
without challenge. However, we have demonstrated that
large-scale xenomonitoring is feasible. In addition to the
challenges of protocol development, sample sizes for
evaluation and availability of technical expertise will
need to be addressed in order to enable Togo and other
country programmes to integrate molecular xenomoni-
toring into their pre- and post-validation surveillance
activities. A further challenge for Togo is to extend the
same survey to the five remaining implementation units
in the country. Given the proximity of areas of ongoing
LF transmission in neighbouring countries, Togo will
need to continue epidemiological and entomological
monitoring and promote key prevention strategies,
such as ITN use, to preserve its achievement and keep
Togo a country where future generations can live free
of LF.
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